February 21, 2022
PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
PrecisionLife Limited has appointed Colin Stubberfield, Ph.D. as SVP Drug Discovery. He will be based at the company’s UK headquarters…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
February 21, 2022
Valneva awarded up to £20 M by Scottish Enterprise to advance vaccine development
Valneva’s subsidiary Valneva Scotland has been awarded research and development funding of up to £20 million by Scottish Enterprise. The…
February 18, 2022
Recipharm acquires Vibalogics and Arranta Bio
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
February 18, 2022
Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest…
February 17, 2022
FDA accepts for priority review BMS’s Breyanzi as a second-line therapy for relapsed or refractory large B-cell lymphoma
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics…
February 17, 2022
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
BioNTech SE (Nasdaq: BNTX, “BioNTech”) has announced that it has taken a next step to improve vaccine supply in Africa.…
February 17, 2022
Intellia and ONK Therapeutics announce collaboration to advance allogeneic CRISPR-edited NK cell therapies for the treatment of patients with cancer
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a genome editing company focused on developing curative therapies leveraging CRISPR-based technologies, and ONK Therapeutics Ltd.,…
February 17, 2022
miDiagnostics ultra-fast COVID-19 PCR test succeeds in Brussels airport pilot study
miDiagnostics, a POC diagnostics company backed by Belgian Family Offices, announces the success of the Brussels Airport pilot study for…
February 16, 2022
Novel Concepts Medical announces breakthrough in COVID-19 research
The startup company Novel Concepts Medical has announced that its novel plant-based treatment has resulted in successfully inhibiting the COVID-19…
February 16, 2022
German Federal Court of Justice upholds AOP’s license rights in Ropeginterferon and PEC’s liability for damages
AOP Orphan Pharmaceuticals announced that on Monday February 14, 2022 the German Federal Court of Justice decided on PEC’s challenge…